Section of Digestive Diseases, Yale University School of Medicine, PO Box 208033, New Haven, CT 06520-8033, USA.
Therap Adv Gastroenterol. 2013 May;6(3):205-13. doi: 10.1177/1756283X13478679.
Diverticulosis is one of the most common gastrointestinal conditions affecting the general population in the Western world. It is estimated that over 2.5 million people are affected by diverticular disease in the United States. The spectrum of clinical manifestations of diverticulosis ranges from asymptomatic diverticulosis to complicated diverticulitis. Treatment for symptomatic diverticular disease is largely based on symptoms. Traditional therapy includes fiber, bowel rest, antibiotics, pain control and surgery for selected cases. This review discusses recent advances in the medical treatment of diverticular disease such as the use of mesalamine, rifaximin and probiotics as our understanding of the disease evolves.
憩室病是影响西方世界普通人群的最常见胃肠道疾病之一。据估计，在美国有超过 250 万人患有憩室疾病。憩室病的临床表现范围从无症状憩室病到复杂的憩室炎。对有症状的憩室病的治疗主要基于症状。传统的治疗包括纤维、肠道休息、抗生素、疼痛控制和对选定病例进行手术。本综述讨论了憩室病的医学治疗的最新进展，例如随着我们对疾病认识的发展，使用美沙拉嗪、利福昔明和益生菌。
